Tau as a Drug Target in Alzheimer’s Disease

By Gozes Illana  

Journal of Molecular Neuroscience, Vol. 19, Iss. 3, 2002-12 ,pp. : 337-338

Humana Press, Inc

Access to resources Recommend Favorite

Tau Mediated Neurodegeneration: An Insight into Alzheimer’s Disease Pathology

By Obulesu M.   Venu R.   Somashekhar R.  

Neurochemical Research, Vol. 36, Iss. 8, 2011-08 ,pp. : 1329-1335

Springer Publishing Company

Access to resources Recommend Favorite

Conformational changes and cleavage; are these responsible for the tau aggregation in Alzheimer’’s disease?

By Mondragóón-Rodrííguez Siddhartha   Basurto-Islas Gustavo   Binder Lester I   Garcíía-Sierra Francisco  

Future Neurology, Vol. 4, Iss. 1, 2009-01 ,pp. : 39-53

Future Medicine

Access to resources Recommend Favorite

Amyloid and tau in the brain in sporadic Alzheimer’s disease: defining the chicken and the egg

By Hawkes Cheryl   Carare Roxana   Weller Roy  

Acta Neuropathologica, Vol. 127, Iss. 4, 2014-04 ,pp. : 617-618

Springer Publishing Company

Access to resources Recommend Favorite

Apolipoprotein E4 as a target for developing new therapeutics for Alzheimer’s disease

By Refolo Lorenzo   Fillit Howard  

Journal of Molecular Neuroscience, Vol. 23, Iss. 3, 2004-10 ,pp. : 151-155

Humana Press, Inc

Access to resources Recommend Favorite